Transplants can be life-saving – but for many, the journey doesn’t end there. Up to 40% of people receiving a stem cell or bone marrow transplant will go on to develop a serious complication known as ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. Regeneron ...

Merck & Co. agreed to buy UK biotech Verona Pharma Plc for about $10 billion as part of a wider push to offset the looming ...

The visit spotlighted the emirate’s achievements in AI, digital health, genomics, and clinical research, and showcased Abu ...

• Diabetes • Internal medicine • Oncology • Thrombosis • Vaccines (through Sanofi Pasteur) Sanofi’s CEO is Christopher A. Viehbacher, who has been in this position since 1st December 2008.

In June 2025, Sanofi announced that its investigational drug riliprubart received orphan drug designation from the US FDA for treating antibody-mediated rejection in solid organ transplantation, ...

Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal ...

SJP Properties announced construction is now underway on Nokia Bell Labs' New Brunswick headquarters, coming to the HELIX ...

Sanofi is speeding up shipping its respiratory syncytial virus (RSV) preventative antibody Beyfortus to get ahead of what it believes will be strong demand in the 2025–26 season.